A Study on the Development and Application of a Cardiac Rehabilitation Nursing Intervention Protocol for Patients With First-Episode Acute Myocardial Infarction Following PCI, Based on a Socio-Ecological Theory Model

August 6, 2026 updated by: Zhang Yuyu, Jinzhou Medical University

The purpose of this [Study Type: Clinical Trial] is to investigate whether a cardiac rehabilitation nursing intervention based on the socio-ecological model can improve rehabilitation-related outcomes in patients. The study population consists of [adult patients with acute myocardial infarction who have undergone percutaneous coronary intervention (PCI)]. The primary research questions addressed in this study are:

  1. Can a social-ecological model-based cardiac rehabilitation intervention improve adherence to cardiac rehabilitation among patients with myocardial infarction following PCI?]
  2. Can a social-ecological model-based cardiac rehabilitation intervention improve cardiac function and quality of life among patients with myocardial infarction following PCI?] The researchers will compare the [intervention group and the control group] to observe whether there are [group differences in cardiac rehabilitation adherence, cardiac function, and quality of life levels].

Intervention group: Receives routine cardiology care combined with a social-ecological model-based cardiac rehabilitation intervention (1. In-hospital guidance; 2. Multidimensional, continuous rehabilitation support at home and in the community; 3. Regular follow-up assessments, etc.); Control Group: Received routine care from the cardiology department and standard discharge cardiac rehabilitation education; All participants completed questionnaire surveys and had cardiac function-related indicators collected at baseline, 3 months into the intervention, and 6 months into the intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Liaoning
      • Jinzhou, Liaoning, China, 121001
        • The First Affiliated Hospital of Jinzhou Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with a first-time diagnosis of acute myocardial infarction who underwent PCI for the first time;
  • Age ≥ 18 years;
  • Alert and able to communicate effectively; ④ Willing to participate and sign an informed consent form.

Exclusion Criteria:

  • Presence of absolute contraindications to exercise (e.g., unstable angina, severe heart failure, malignant arrhythmias, etc.);
  • Concurrent severe comorbidities (e.g., end-stage renal disease, malignant tumors, severe cognitive impairment);
  • Participation in other rehabilitation clinical trials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Other: A Cardiac Rehabilitation Nursing Intervention Program Based on the Social-Ecological Theory Model
Building on routine cardiac nursing care, implement a cardiac rehabilitation nursing intervention based on the socio-ecological model, with an intervention period of 1 month. Interventions were carried out at the individual, interpersonal, organizational, community, and policy levels: at the individual level, guidance was provided on exercise, diet, medication, and emotional management; at the organizational level, a multidisciplinary rehabilitation team was established; at the interpersonal level, family members were mobilized to participate in collaborative care; at the community level, a system of continuous follow-up management was established, with monthly online and in-person rehabilitation guidance and assessments; and at the policy level, policy interpretation and guidance were provided to different population groups.
No Intervention: Control Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Left Ventricular Ejection Fraction
Time Frame: From enrollment through the end of the three-month follow-up
From enrollment through the end of the three-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Jinzhou Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2026

Primary Completion (Actual)

June 20, 2026

Study Completion (Actual)

June 20, 2026

Study Registration Dates

First Submitted

August 3, 2026

First Submitted That Met QC Criteria

August 6, 2026

First Posted (Actual)

August 10, 2026

Study Record Updates

Last Update Posted (Actual)

August 10, 2026

Last Update Submitted That Met QC Criteria

August 6, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • JZMULL2025435

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To protect patient privacy, all raw data will be uploaded to the ResMan Clinical Trial Management Platform (https://www.myresman.com/) six months after the study is completed.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe